Ranbaxy gets Health Canada nod for generic anti-dementia drug – Economic Times


Economic Times

Ranbaxy gets Health Canada nod for generic anti-dementia drug
Economic Times
NEW DELHI: Drug maker Ranbaxy Laboratories today announced receipt of approval from Health Canada to sell generic version of Pfizer's Aricept, a drug used for treatment of dementia in Alzheimer's patients. The approval by Health Canada is given to ...
Canada Approves Ranbaxy's Dementia DrugDrug Discovery & Development
Ranbaxy gets approval to market Donepezil tablets in CanadaHindu Business Line

all 12 news articles »